Pemphigus and quality of life

Dermatologic Clinics

Volumn 29, Issue 3, 2011, Pages 521-525

  Chee, Shien Ning ^a   Murrell, Dédée F ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Autoimmune condition; Pemphigus; Quality of life; Skin

Indexed keywords

CLINICAL EFFECTIVENESS; DISEASE SEVERITY; HUMAN; PATIENT CARE; PATIENT MONITORING; PEMPHIGUS; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; REVIEW;

HEALTH STATUS; HUMANS; PEMPHIGUS; QUALITY OF LIFE;

EID: 79956284302     PISSN: 07338635     EISSN: 15580520     Source Type: Journal    
DOI: 10.1016/j.det.2011.03.009     Document Type: Review

References (23)

1. Abeni D., Picardi A., Pasquini P., et al. Further evidence of the validity and reliability of the Skindex-29: an Italian study on 2,242 dermatological outpatients. Dermatology 2002, 204:43-49.
2. Maroti M., Ulff E., Wijma B. Quality of life before and 6 weeks after treatment in a dermatological outpatient treatment unit. J Eur Acad Dermatol Venereol 2006, 20(9):1081-1085.
3. Renzi C., Tabbolli S., Picardi A., et al. Effects of patient satisfaction with care on health-related quality of life: a prospective study. J Eur Acad Dermatol Venereol 2005, 19:712-718.
4. Hertl M. Autoimmune disease of the skin 2005, Springer-Verlag, Wien (Austria). 2nd edition.
5. Bhosle M., Kulkarni A., Feldman S., et al. Quality of life in patients with psoriasis. Health Qual Life Outcome 2006, 4(35):1-7.
6. Ware J., Sherbourne C. The MOS 36-item short-form health survey. Med Care 1992, 30(6):473-483.
7. Finlay A. Quality of life measurement in dermatology: a practical guide. Br J Dermatol 1997, 136(3):305-314.
8. Finlay A., Khan G. Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use. Clin Exp Dermatol 1994, 19:210-216.
9. Nijsten T., Sampogna F., Chren M., et al. Testing and reducing Skindex-29 using Rasch analysis: Skindex-17. J Invest Dermatol 2006, 126:1244-1250.
10. Cohen A., Ofek-Schlomai A., Vardy D., et al. Depression in dermatological patients identified by the mini international neuropsychiatric interview questionnaire. J Am Acad Dermatol 2005, 54(1):94-99.
11. Paradisi A., Sampogna F., Di Pietro C., et al. Quality-of-life assessment in patients with pemphigus using a minimum set of evaluation tools. J Am Acad Dermatol 2009, 60(2):261-269.
12. Masahiro S., Shigaku I., Yutaka I., et al. An investigation of quality of life (QOL) of pemphigus patients in Japan (First report). Jpn J Dermatol 2000, 110:283-288.
13. Mayrshofer F., Hertl M., Sinkgraven R., et al. J Dtsch Dermatol Ges 2005, 3(6):431-435. [in German].
14. Terrab Z., Benchikhi H., Maaroufi A., et al. Qualite de vie et pemphigus [Quality of life and pemphigus]. Ann Dermatol Venereol 2005, 132(4):321-328. [in French].
15. Tabolli S., Mozzetta A., Antinone V., et al. The health impact of pemphigus vulgaris and pemphigus foliaceus assessed using the medical outcomes study 36-Item Short Form Health Survey Questionnaire. Br J Dermatol 2008, 158(5):1029-1034.
16. Kirtschig G., Middleton P., Bennett C., et al. Interventions for bullous pemphigoid. Cochrane Database of Systematic Reviews 2010, 10. CD002292.
17. Martin L.K., Agero A.L., Werth V., et al. Interventions for pemphigus vulgaris and pemphigus foliaceus. Cochrane Database of Systematic Reviews 2009, 1. CD006263.
18. Kiebzak G., Pierson L., Campbell M., et al. Use of the SF36 general health status survey to document health-related quality of life in patients with coronary artery disease: effect of disease and response to coronary artery bypass graft surgery. Heart Lung 2002, 31(3):207-213.
19. Perry S., Kowalski T., Chang C. Quality of life assessment in women with breast cancer: benefits, acceptability and utilization. Health Qual Life Outcome 2007, 5:24.
20. Chee S., Martin L., Murrell D. The development of a specific quality of life score for patients with pemphigus. Australas J Dermatol 2008, 49(Suppl 1):A42.
21. Chee S., Martin L., Murrell D. The development of a quality of life instrument specific for pemphigus. J Invest Dermatol 2009, 129:2908-2923.
22. Sebaratnam D., Chee S.N., Venugopal S., et al. Advances in the clinical assessment of autoimmune bullous disease: the development of a disease-specific quality of life instrument - the ABQOL. J Invest Dermatol 2009, 129:2908-2923.
23. Hanna A, Sebaratnam D, Chee S, et al. The development of a disease-specific quality of life instrument for autoimmune bullous diseases - the ABQOL [poster], in Medical Dermatology Society Meeting. Miami, March 5, 2010.